Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Diabetic Peripheral Neuropathy - Overview
Diabetic Peripheral Neuropathy - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Diabetic Peripheral Neuropathy - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Diabetic Peripheral Neuropathy - Companies Involved in Therapeutics Development
Achelios Therapeutics Inc
Applied Therapeutics Inc
Bionevia Pharmaceuticals
Calchan Ltd
Celularity Inc
CSPC Pharmaceutical Group Ltd
Eliem Therapeutics Inc
Exodos Life Sciences Limited Partnership
GNT Pharma Co Ltd
Grunenthal GmbH
Immune Pharmaceuticals Inc
Ion Channel Pharmacology LLC
Jiangsu Aosaikang Pharmaceutical Co Ltd
Korea United Pharm Inc
Medifron DBT Co Ltd
Mitsubishi Tabe Pharma Corp
Praetego Inc
Pure Green Pharmaceuticals Inc
Reata Pharmaceuticals Inc
Seneca Biopharma Inc
Sonnet BioTherapeutics Holdings Inc
Sphaera Pharma Pte Ltd
Winsantor Inc
Zhejiang Pharmaceutical Co Ltd
Diabetic Peripheral Neuropathy - Drug Profiles
(amitriptyline + ketamine hydrochloride) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diclofec sodium + triclocarban) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AAD-2004 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AT-001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BNV-222 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CNV-2197944 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
dextrose lipoic acid tromethamine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
elismetrep - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ETX-018810 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ketoprofen - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KU-32 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MDR-16523 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MDR-652 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NSI-189 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PDA-002 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PGDN-20WS - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pirenzepine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PTG-605 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
resiniferatoxin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RTA-901 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Agonize MOR1 for Chemotherapy Induced Peripheral Neuropathy, Diabetic Peripheral Neuropathy and Postherpetic Neuralgia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Pain - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SON-081 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SYHA-1402 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
UI-048 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
YJ-001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Diabetic Peripheral Neuropathy - Dormant Projects
Diabetic Peripheral Neuropathy - Discontinued Products
Diabetic Peripheral Neuropathy - Product Development Milestones
Featured News & Press Releases
Sep 30, 2020: Praetego receives NIH phase 2 STTR funding to advance novel amadorin drug candidates for diabetic peripheral neuropathy
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Diabetic Peripheral Neuropathy, 2021
Number of Products under Development by Companies, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Top 10 Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Top 10 Molecule Types, 2021


List of Tables


Number of Products under Development for Diabetic Peripheral Neuropathy, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Diabetic Peripheral Neuropathy - Pipeline by Achelios Therapeutics Inc, 2021
Diabetic Peripheral Neuropathy - Pipeline by Applied Therapeutics Inc, 2021
Diabetic Peripheral Neuropathy - Pipeline by Bionevia Pharmaceuticals, 2021
Diabetic Peripheral Neuropathy - Pipeline by Calchan Ltd, 2021
Diabetic Peripheral Neuropathy - Pipeline by Celularity Inc, 2021
Diabetic Peripheral Neuropathy - Pipeline by CSPC Pharmaceutical Group Ltd, 2021
Diabetic Peripheral Neuropathy - Pipeline by Eliem Therapeutics Inc, 2021
Diabetic Peripheral Neuropathy - Pipeline by Exodos Life Sciences Limited Partnership, 2021
Diabetic Peripheral Neuropathy - Pipeline by GNT Pharma Co Ltd, 2021
Diabetic Peripheral Neuropathy - Pipeline by Grunenthal GmbH, 2021
Diabetic Peripheral Neuropathy - Pipeline by Immune Pharmaceuticals Inc, 2021
Diabetic Peripheral Neuropathy - Pipeline by Ion Channel Pharmacology LLC, 2021
Diabetic Peripheral Neuropathy - Pipeline by Jiangsu Aosaikang Pharmaceutical Co Ltd, 2021
Diabetic Peripheral Neuropathy - Pipeline by Korea United Pharm Inc, 2021
Diabetic Peripheral Neuropathy - Pipeline by Medifron DBT Co Ltd, 2021
Diabetic Peripheral Neuropathy - Pipeline by Mitsubishi Tanabe Pharma Corp, 2021
Diabetic Peripheral Neuropathy - Pipeline by Praetego Inc, 2021
Diabetic Peripheral Neuropathy - Pipeline by Pure Green Pharmaceuticals Inc, 2021
Diabetic Peripheral Neuropathy - Pipeline by Reata Pharmaceuticals Inc, 2021
Diabetic Peripheral Neuropathy - Pipeline by Seneca Biopharma Inc, 2021
Diabetic Peripheral Neuropathy - Pipeline by Sonnet BioTherapeutics Holdings Inc, 2021
Diabetic Peripheral Neuropathy - Pipeline by Sphaera Pharma Pte Ltd, 2021
Diabetic Peripheral Neuropathy - Pipeline by Winsantor Inc, 2021
Diabetic Peripheral Neuropathy - Pipeline by Zhejiang Pharmaceutical Co Ltd, 2021
Diabetic Peripheral Neuropathy - Dormant Projects, 2021
Diabetic Peripheral Neuropathy - Dormant Projects, 2021 (Contd..1)
Diabetic Peripheral Neuropathy - Discontinued Products, 2021